Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis

• DOI: 10.1161/circresaha.107.155655
• Publication Date: 2007-07-20T01:14:51Z
• Authors: Ganapati H. Mahab...; Weiyi Feng; Kumar Reddy; Edward F. Plow; Tatiana V. Byzova
• Keywords: Cytoplasm; Indoles; Integrin beta3; Endothelial Cells; Neovascularization, Physiologic; Receptor Cross-Talk; Integrin alphaVbeta3; Kinetics; Mice; Cell Movement; Multiprotein Complexes; Cell Adhesion; Animals; Humans; Collagen; Laminin; Phosphorylation; Protein Kinase Inhibitors; Cells, Cultured; Signal Transduction

The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cross-activation between β 3 integrin and tyrosine kinase receptor 2 for vascular endothelial growth factor (VEGF) receptor (VEGFR-2) on endothelium. The relationship between VEGFR-2 and β 3 integrin appears to be synergistic, because VEGFR-2 activation induces β 3 integrin tyrosine phosphorylation, which, in turn, is crucial for VEGF-induced tyrosine phosphorylation of VEGFR-2. We demonstrate here that adhesion- and growth factor–induced β 3 integrin tyrosine phosphorylation are directly mediated by c-Src. VEGF-stimulated recruitment and activation of c-Src and subsequent β 3 integrin tyrosine phosphorylation are critical for interaction between VEGFR-2 and β 3 integrin. Moreover, c-Src mediates growth factor–induced β 3 integrin activation, ligand binding, β 3 integrin-dependent cell adhesion, directional migration of endothelial cells, and initiation of angiogenic programming in endothelial cells. Thus, the present study determines the molecular mechanisms and consequences of the synergism between 2 cell surface receptor systems, growth factor receptor and integrins, and opens new avenues for the development of pro- and antiangiogenic strategies.